MPM Oncology Impact Management »

Alx Oncology Hldgs shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Alx Oncology Hldgs (ALXO) shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Alx Oncology Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Alx Oncology Hldgs held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alx Oncology Hldgs by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $14M 1.3M 11.15

More positions owned by MPM Oncology Impact Management

Cullinan Oncology Common (CGEM)
Geron Corporation Common (GERN)
Iovance Biotherapeutics Common (IOVA)
Zentalis Pharmaceuticals Common (ZNTL)
iTeos Therapeutics Common (ITOS)
Sutro Biopharma Common (STRO)
Crinetics Pharmaceuticals Common (CRNX)
Olema Pharmaceuticals Common (OLMA)
Madrigal Pharmaceuticals Common (MDGL)
Natera Common (NTRA)
Werewolf Therapeutics Common (HOWL)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Avadel Pharmaceuticals Sponsored ADR (AVDL)
Insmed Incorporated Common (INSM)
ALX Oncology Holdings Common (ALXO)

View all positions for MPM Oncology Impact Management

Top funds holding Alx Oncology Hldgs

venBio Partners
FMR
Redmile Group
Vivo Capital
Cormorant Asset Management
OrbiMed Advisors
BlackRock
Vanguard Group
MPM Oncology Impact Management
Citadel Advisors
Geode Capital Management
State Street Corporation
Morgan Stanley
Northern Trust
Renaissance Technologies

View all funds holding Alx Oncology Hldgs